Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GBA1 | P04062 | 3/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | IGF2R | P11717 | 4/20 | 0.43 |
| ▸ | SELL | P14151 | 6/20 | 0.43 |
| ▸ | SELP | P16109 | 6/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15618706 | 1.00 | GBA1 (0.55) | GBA1MAPK1IGF2RSELLSELP | |
| SCHEMBL301659 | 1.00 | GBA1 (0.55) | GBA1MAPK1IGF2RSELLSELP | |
| SCHEMBL15618707 | 1.00 | GBA1 (0.55) | GBA1MAPK1IGF2RSELLSELP | |
| SCHEMBL15618393 | 1.00 | GBA1 (0.55) | GBA1MAPK1IGF2RSELLSELP | |
| SCHEMBL15618264 | 1.00 | GBA1 (0.55) | GBA1MAPK1IGF2RSELLSELP | |
| SCHEMBL15618678 | 1.00 | GBA1 (0.55) | GBA1MAPK1IGF2RSELLSELP | |
| SCHEMBL13429018 | 1.00 | GBA1 (0.55) | GBA1MAPK1IGF2RSELLSELP | |
| SCHEMBL15628334 | 1.00 | GBA1 (0.55) | GBA1MAPK1IGF2RSELLSELP | |
| SCHEMBL20090269 | 1.00 | GBA1 (0.55) | GBA1MAPK1IGF2RSELLSELP | |
| SCHEMBL15618676 | 1.00 | GBA1 (0.55) | GBA1MAPK1IGF2RSELLSELP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020215142-A1 | MULTIFUNCTIONAL LIPOSOMES, COMPOSITIONS, USES AND METHODS FOR THE PREPARATION THEREOF | LÍBERA TECNOLOGIA E INOVAÇÃO LTDA. (BR) | 2020-10-29 | — | — | WO | disclosed |
| WO-2020215136-A1 | MULTIFUNCTIONAL LIPOSOMES, COMPOSITIONS, USES AND METHODS FOR PREPARING SAME | FUNDAÇÃO DE AMPARO À PESQUISA DO ESTADO DE SÃO PAULO - FAPESP (BR) | 2020-10-29 | — | — | WO | disclosed |
| US-20190336542-A1 | SYNTHETIC BACTERIA AND METHODS OF USE | SYMBIOME, INC. | 2019-11-07 | — | — | US | disclosed |
| WO-2017185018-A1 | SYNTHETIC BACTERIA AND METHODS OF USE | NAKED BIOME, INC. (US) | 2017-10-26 | — | — | WO | disclosed |
| US-9163049-B2 | Medicament comprising a reducing alkyl-sugar monomer for the treatment of inflammatory disorders | PIERRE FABRE DERMO-COSMETIQUE (FR) | 2015-10-20 | — | — | US | disclosed |
| US-20100069311-A1 | MEDICAMENT COMPRISING A REDUCING ALKYL-SUGAR MONOMER FOR THE TREATMENT OF INFLAMMATORY DISORDERS | HOULMONT JEAN-PHILIPPE | 2010-03-18 | — | — | US | disclosed |
| US-7666847-B2 | Medicament comprising a reducing alkyl-sugar monomer for the treatment of inflammatory disorders | PIERRE FABRE DERMO-COSMETIQUE (FR) | 2010-02-23 | — | — | US | disclosed |
| US-20070134187-A1 | Medicament comprising a reducing alkyl-sugar monomer for the treatment of inflammatory disorders | CENTRE NATIONAL DE LA RECHESRCHE SCIENTIFIQUE (CNRS) (FR) | 2007-06-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100069311-A1 | MEDICAMENT COMPRISING A REDUCING ALKYL-SUGAR MONOMER FOR THE TREATMENT OF INFLAMMATORY DISORDERS | UGCG, UGGT1, TLR6 | GBA1 65/4885MAPK1 1284/4885IGF2R 911/4885 |
| US-20070134187-A1 | Medicament comprising a reducing alkyl-sugar monomer for the treatment of inflammatory disorders | UGCG, TLR6, CD68 | GBA1 70/4885MAPK1 1211/4885IGF2R 1217/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.